pyrazines has been researched along with Alcohol Drinking in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, W; Gao, A; Guo, M; Herman, JG; Jiao, S; Wang, L; Zhang, L | 1 |
| Bardag-Gorce, F; French, SW; Li, J; Oliva, J | 1 |
2 other study(ies) available for pyrazines and Alcohol Drinking
| Article | Year |
|---|---|
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Damage; DNA Repair; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; GPI-Linked Proteins; Heterografts; Humans; Male; Methylation; Mice; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Neuropeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Pyrazines; Pyrazoles; TOR Serine-Threonine Kinases; Tumor Burden | 2021 |
Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis.
Topics: Alcohol Drinking; Animals; Antineoplastic Agents; Apolipoproteins; Boronic Acids; Bortezomib; Cholesterol; Down-Regulation; Fatty Acids; Fatty Liver, Alcoholic; Intestinal Absorption; Lipid Metabolism; Male; Proteasome Inhibitors; Pyrazines; Rats; Rats, Wistar; Triglycerides | 2012 |